News

December 11, 2018

First Patient Dosed with VY-AADC Gene Therapy in Parkinson’s Phase 2 Trial

News

Voyager Therapeutics has begun patient dosing in a Phase 2 trial testing its investigational VY-AADC gene therapy in Parkinson’s patients whose motor symptoms are not responding adequately to oral medication. The ... Read more

December 11, 2018

Gut Bacteria Composition Linked to Parkinson’s Disease Severity, Study Shows

News

The composition of intestinal bacteria in patients with Parkinson’s disease is correlated with disease severity and a worse prognosis, a study has found. The study, “Gut microbiota are related ... Read more

December 10, 2018

IRL790 Is Safe, Reduces Levodopa-induced Dyskinesia in Parkinson’s, Phase 1b Trial Shows

News

IRL790, Integrative Research Laboratories‘ investigational treatment for Parkinson’s disease patients, was safe and reduced levodopa-induced dyskinesia, a Phase 1b trial shows. The results were published in the journal npj Parkinson’s Disease in ... Read more

December 10, 2018

Older IBD Patients Show Increased Risk for Parkinson’s Disease, Study Suggests

News

Older patients with inflammatory bowel disease (IBD) are more likely to develop Parkinson’s disease than those without the condition, a meta-analysis suggests. Whether the same association exists for younger patients — ... Read more

December 7, 2018December 7, 2018

Low Doses of Herbicide and Lectins Led to Parkinsonism in Animals, Study Reports

News

Ingesting a once widely used herbicide called paraquat along with lectins — proteins in common foods that bind carbohydrates (e.g., sugars) — can lead to symptoms typical of Parkinson’s ... Read more

December 7, 2018December 7, 2018

Medical Marijuana and Its Use Focus of March Meeting Set by Parkinson’s Foundation

News

With the goal of establishing a consensus on medical marijuana use by Parkinson’s patients — which a recent survey co-sponsored by the Parkinson’s Foundation put at 80 percent — the group will host ... Read more

December 6, 2018December 6, 2018

World War II Chemical Weapon Antidote May Also Fight Parkinson’s, Researchers Suggest

News

Dimercaprol, an antidote to a World War II chemical weapon, was shown to be effective in removing a neurotoxin associated with Parkinson’s, revealing it as a possible treatment for ... Read more

December 6, 2018December 6, 2018

Enzyme Linking Fatty Acids to Alpha-synuclein Could Be Parkinson’s Therapeutic Target, Study Suggests

News

Inhibiting an enzyme that regulates the production of fatty acids may protect against brain toxicity induced by alpha-synuclein in Parkinson’s disease and may become a therapeutic target for these patients, ... Read more

December 5, 2018December 5, 2018

Taste, Smell Impairments May Help Identify People at Risk for Parkinson’s, Study Suggests

News

Impaired sense of smell or taste can raise a person’s risk of developing Parkinson’s disease 2.5 times, a study suggests. The study, “Incidence of Parkinson’s disease in a large patient ... Read more

December 5, 2018December 11, 2018

Focused-ultrasound Lesion Surgery Can Treat Tremors and Improve Life Quality, Study Says

News

Treating tremor in Parkinson’s patients using non-invasive and focused-ultrasound lesion surgery is associated with better quality of life when compared to deep brain stimulation, although both approaches are equally effective in easing this disease ... Read more

Pin It on Pinterest